Tag Archive: Cancer
Australia’s 60 Minutes recently revisited its story from last year about the revolutionary immune therapy treatment spearheaded by The Children’s Hospital of Philadelphia’s Stephan A. Grupp, MD, PhD.
Permanent link to this article: http://www.research.chop.edu/blog/60-minutes-revisits-cancer-therapy-pioneered-chop/
Dr. Grupp has received a great deal of attention for his investigation of using cell therapy to treat an aggressive form of childhood leukemia, acute lymphoblastic leukemia (ALL).
Permanent link to this article: http://www.research.chop.edu/blog/hat-trick-cell-therapy-expert-scores-trio-honors/
Beverly J. Lange, MD, an exemplary physician and researcher at The Children’s Hospital of Philadelphia (CHOP) for over 40 years, received the 2014 Distinguished Career Award from the American Society of Pediatric Hematology/Oncology (ASPHO).
Permanent link to this article: http://www.research.chop.edu/blog/distinguished-career-award-goes-chop-oncologist/
Dr. Kalish recently received an award from the Alex’s Lemonade Stand Foundation to investigate tumor development associated with the rare childhood overgrowth disease Beckwith-Wiedemann Syndrome.
Permanent link to this article: http://www.research.chop.edu/blog/rare-disease-study-broaden-tumor-development-understanding/
As part of its commitment to training the next generation of pediatric pioneers, every year CHOP Research takes time to honor its exceptional trainees, and recently announced the 2014 Distinguished Research Trainee Award winners.
Permanent link to this article: http://www.research.chop.edu/blog/illustrating-commitment-education-chop-research-honors-trainees/
The term “stem cell,” stammzellen, was first used in 1868 by the German biologist Ernst Haeckel to describe the original, unicellular progenitor from which Dr. Haekel supposed all multicellular plant and animal life might have descended.
Permanent link to this article: http://www.research.chop.edu/blog/treating-chicken-egg/
Established in 2001, the Commonwealth Universal Research Enhancement (CURE) program awards grants to biomedical, clinical, and health services research projects.
Permanent link to this article: http://www.research.chop.edu/blog/cure-awards-support-genomic-screening-studies-2/
Kids who survive cancer may face a variety of physical and emotional challenges as a result of their treatment. One of these is the possibility of infertility following cancer treatment.
Permanent link to this article: http://www.research.chop.edu/blog/experimental-program-seeks-preserve-cancer-patients-fertility/
Proton therapy, which uses high-energy subatomic particles, may offer a precise, organ-sparing treatment option for children with high-risk forms of neuroblastoma, the most common solid tumor of early childhood.
Permanent link to this article: http://www.research.chop.edu/blog/proton-therapy-offers-new-precise-cancer-treatment-children-high-risk-neuroblastoma/
Children’s Hospital investigators may have developed a completely new type of cancer immunotherapy, one that involves harnessing the body’s immune system to attack tumors.
Permanent link to this article: http://www.research.chop.edu/blog/chop-researchers-advance-new-anti-tumor-immunotherapy-approach/